Technical Analysis for PXMD - PaxMedica, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Narrow Range Bar | Range Contraction | 27.29% | |
| Wide Bands | Range Expansion | 27.29% | |
| Gapped Down | Weakness | 27.29% | |
| Oversold Stochastic | Weakness | 27.29% | |
| Narrow Range Bar | Range Contraction | 15.17% | |
| Wide Bands | Range Expansion | 15.17% | |
| Oversold Stochastic | Weakness | 15.17% | |
| New 52 Week Closing Low | Bearish | 27.29% |
| Alert | Time |
|---|---|
| Rose Above 10 DMA | about 10 hours ago |
| 10 DMA Resistance | about 11 hours ago |
| 60 Minute Opening Range Breakout | about 14 hours ago |
| Rose Above Previous Day's High | about 15 hours ago |
| Up 5% | about 15 hours ago |
Get a Trading Sidekick!
- Earnings date: Unknown
PaxMedica, Inc. Description
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, and human african trypanosomiasis. It is also involved in developing PAX-102, an intranasal formulation of suramin for neurologic indications. The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was incorporated in 2018 and is based in Tarrytown, New York. PaxMedica, Inc. operates as a subsidiary of Tardimed Sciences LLC.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Disorders Chronic Condition Drug Therapies Autism Spectrum Disorder Chronic Fatigue Syndrome
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 27.03 |
| 52 Week Low | 0.201 |
| Average Volume | 3,007,049 |
| 200-Day Moving Average | 2.70 |
| 50-Day Moving Average | 0.56 |
| 20-Day Moving Average | 0.49 |
| 10-Day Moving Average | 0.26 |
| Average True Range | 0.09 |
| RSI (14) | 35.90 |
| ADX | 25.85 |
| +DI | 23.90 |
| -DI | 30.98 |
| Chandelier Exit (Long, 3 ATRs) | 0.62 |
| Chandelier Exit (Short, 3 ATRs) | 0.47 |
| Upper Bollinger Bands | 0.97 |
| Lower Bollinger Band | 0.01 |
| Percent B (%b) | 0.26 |
| BandWidth | 194.49 |
| MACD Line | -0.11 |
| MACD Signal Line | -0.08 |
| MACD Histogram | -0.032 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.36 | ||||
| Resistance 3 (R3) | 0.35 | 0.31 | 0.34 | ||
| Resistance 2 (R2) | 0.31 | 0.29 | 0.31 | 0.34 | |
| Resistance 1 (R1) | 0.29 | 0.27 | 0.30 | 0.30 | 0.33 |
| Pivot Point | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
| Support 1 (S1) | 0.22 | 0.22 | 0.23 | 0.23 | 0.19 |
| Support 2 (S2) | 0.18 | 0.21 | 0.19 | 0.19 | |
| Support 3 (S3) | 0.16 | 0.18 | 0.18 | ||
| Support 4 (S4) | 0.17 |
